INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 36 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13,509,377 | +4.9% | 13,507,000 | +3.8% | 0.41% | -6.4% |
| Q4 2022 | $12,877,281 | +318.6% | 13,007,000 | +311.2% | 0.44% | +601.6% |
| Q3 2022 | $3,076,000 | +0.3% | 3,163,000 | 0.0% | 0.06% | +51.2% |
| Q2 2022 | $3,068,000 | +0.6% | 3,163,000 | -4.7% | 0.04% | +46.4% |
| Q1 2022 | $3,050,000 | -3.0% | 3,320,000 | 0.0% | 0.03% | +64.7% |
| Q4 2021 | $3,144,000 | -94.6% | 3,320,000 | -94.9% | 0.02% | -92.8% |
| Q2 2021 | $58,191,000 | +40.3% | 64,548,000 | +28.8% | 0.24% | +12.9% |
| Q1 2021 | $41,465,000 | +199.4% | 50,109,000 | +186.3% | 0.21% | +198.6% |
| Q4 2020 | $13,850,000 | – | 17,500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $56,098,000 | 1.12% |
| L & S Advisors Inc | 795,000 | $767,000 | 0.14% |
| OAKTREE CAPITAL MANAGEMENT LP | 9,964,000 | $9,690,000 | 0.11% |
| WEDBUSH SECURITIES INC | 13,000 | $1,251,000 | 0.07% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,163,000 | $3,076,000 | 0.06% |
| ZAZOVE ASSOCIATES LLC | 246,000 | $240,000 | 0.02% |
| Balboa Wealth Partners | 21,000 | $20 | 0.01% |
| Russell Investments Group, Ltd. | 1,910,000 | $1,875,000 | 0.00% |
| GAMCO INVESTORS, INC. ET AL | 250,000 | $244,000 | 0.00% |
| Regal Investment Advisors LLC | 20,000 | $19,000 | 0.00% |